Overview

Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott
Treatments:
Cholinesterase Inhibitors